PensionDanmark’s Biogen BIIB Stock Holding History

PensionDanmark’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Sell	10,506 -488	-4%	-$93.3K	0.02%	442
2026 Q1	$2.02M	Buy	10,994 +1,832	+20%	+$338K	0.02%	454
2025 Q4	$1.61M	Buy	+9,162	New	+$1.5M	0.01%	468

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PensionDanmark's BIIB Position: Q2 2026 in Review

PensionDanmark reduced its Biogen (BIIB) stake by 4.4% in Q2 2026, selling an estimated $93.3K and leaving 10,506 shares worth $2.27M. The position accounts for 0.02% of the portfolio, ranked #442.

PensionDanmark first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

PensionDanmark held 10,506 shares of Biogen worth $2.27M as of Q2 2026.
PensionDanmark sold 488 Biogen shares in Q2 2026, an estimated $93.3K.
Biogen made up 0.02% of PensionDanmark's portfolio in Q2 2026, its #442 holding.
PensionDanmark first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on PensionDanmark's 13F filing for Q2 2026, filed 8 Jul 2026.